Suppression of orthotopically implanted hepatocarcinoma in mice by umbilical cord-derived mesenchymal stem cells with sTRAIL gene expression driven by AFP promoter.
暂无分享,去创建一个
Jianxiang Wang | Ming Yang | D. Xiong | Shuangjing Li | D. Fan | Zhen-zhen Li | Cihui Yan | Yan-jun Zhang | Xiao Hu
[1] T. Vanhaecke,et al. Characterization of hepatic markers in human Wharton's Jelly-derived mesenchymal stem cells. , 2014, Toxicology in vitro : an international journal published in association with BIBRA.
[2] Lei Shi,et al. Hepatocellular carcinoma‐associated mesenchymal stem cells promote hepatocarcinoma progression: Role of the S100A4‐miR155‐SOCS1‐MMP9 axis , 2013, Hepatology.
[3] Y. Rui,et al. Bone marrow-derived mesenchymal stem cells promote growth and angiogenesis of breast and prostate tumors , 2013, Stem Cell Research & Therapy.
[4] Yi Zhu,et al. Development of a gene therapy strategy to target hepatocellular carcinoma based inhibition of protein phosphatase 2A using the α-fetoprotein promoter enhancer and pgk promoter: an in vitro and in vivo study , 2012, BMC Cancer.
[5] Lanjuan Li,et al. In vivo hepatic differentiation of mesenchymal stem cells from human umbilical cord blood after transplantation into mice with liver injury. , 2012, Biochemical and biophysical research communications.
[6] M. Choolani,et al. Human umbilical cord wharton's jelly stem cell (hWJSC) extracts inhibit cancer cell growth in vitro , 2012, Journal of cellular biochemistry.
[7] M. Choolani,et al. Human umbilical cord wharton's jelly mesenchymal stem cells do not transform to tumor‐associated fibroblasts in the presence of breast and ovarian cancer cells unlike bone marrow mesenchymal stem cells , 2012, Journal of cellular biochemistry.
[8] D. Kopecko,et al. Antitumor effects of Stat3-siRNA and endostatin combined therapies, delivered by attenuated Salmonella, on orthotopically implanted hepatocarcinoma , 2012, Cancer Immunology, Immunotherapy.
[9] M. Choolani,et al. Extra-embryonic human Wharton's jelly stem cells do not induce tumorigenesis, unlike human embryonic stem cells. , 2012, Reproductive biomedicine online.
[10] F. Schwab,et al. Selective Targeting of Genetically Engineered Mesenchymal Stem Cells to Tumor Stroma Microenvironments Using Tissue-Specific Suicide Gene Expression Suppresses Growth of Hepatocellular Carcinoma , 2011, Annals of surgery.
[11] Li-Ling Chak,et al. Human Wharton’s Jelly Stem Cells Have Unique Transcriptome Profiles Compared to Human Embryonic Stem Cells and Other Mesenchymal Stem Cells , 2011, Stem Cell Reviews and Reports.
[12] C. Yun,et al. A Hypoxia- and α-Fetoprotein–Dependent Oncolytic Adenovirus Exhibits Specific Killing of Hepatocellular Carcinomas , 2010, Clinical Cancer Research.
[13] S. Fulda,et al. Targeting of XIAP Combined with Systemic Mesenchymal Stem Cell‐Mediated Delivery of sTRAIL Ligand Inhibits Metastatic Growth of Pancreatic Carcinoma Cells , 2010, Stem cells.
[14] S. Hwang,et al. Effect of human umbilical cord blood‐derived mesenchymal stem cells in a cirrhotic rat model , 2009, Liver international : official journal of the International Association for the Study of the Liver.
[15] A. Quiñones‐Hinojosa,et al. Applications of neural and mesenchymal stem cells in the treatment of gliomas , 2009, Expert review of anticancer therapy.
[16] Y. Sung,et al. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma. , 2008, Cancer research.
[17] R. Senekowitsch-Schmidtke,et al. α-Fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma , 2008, Gene Therapy.
[18] Ross Tubo,et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis , 2007, Nature.
[19] J. Hengstler,et al. Functional integration of hepatocytes derived from human mesenchymal stem cells into mouse livers , 2006, Gut.
[20] A. Rosenwald,et al. Cancers as wounds that do not heal: differences and similarities between renal regeneration/repair and renal cell carcinoma. , 2006, Cancer research.
[21] I. Ghiran,et al. Human Bone Marrow Stromal Cells Express a Distinct Set of Biologically Functional Chemokine Receptors , 2006, Stem cells.
[22] Q. Xie,et al. Human umbilical cord Wharton's Jelly-derived mesenchymal stem cells differentiation into nerve-like cells. , 2005, Chinese medical journal.
[23] T. Takayama,et al. Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion. , 2005, Blood.
[24] H. Eguchi,et al. Partial Contribution of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)/TRAIL Receptor Pathway to Antitumor Effects of Interferon-α/5-Fluorouracil against Hepatocellular Carcinoma , 2004, Clinical Cancer Research.
[25] O. Lee,et al. In vitro hepatic differentiation of human mesenchymal stem cells , 2004, Hepatology.
[26] D. Seol,et al. The secretable form of trimeric TRAIL, a potent inducer of apoptosis. , 2004, Biochemical and biophysical research communications.
[27] W. Stremmel,et al. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs , 2004, Cell Death and Differentiation.
[28] L. Rénia,et al. Bone marrow transplantation in mice leads to a minor population of hepatocytes that can be selectively amplified in vivo , 2002, Hepatology.
[29] D. Lawrence,et al. Safety and antitumor activity of recombinant soluble Apo2 ligand. , 1999, The Journal of clinical investigation.
[30] C. Rauch,et al. Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivo , 1999, Nature Medicine.
[31] D. Prockop,et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.
[32] M. Fukushima,et al. Potentiation of the sensitivity of renal cell carcinoma cells to TRAIL-mediated apoptosis by subtoxic concentrations of 5-fluorouracil. , 2002, European journal of cancer.
[33] Friedenstein Aj,et al. Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. , 1974 .